Peter Wolfe insider trades
Open-market stock purchases and sales by Peter Wolfe, Chief Financial Officer at ZyVersa Therapeutics, Inc, from SEC Form 4 filings since Dec 12, 2022.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ZVSA ZyVersa Therapeutics, Inc: other filings, last Jul 11, 2025